DENVER, January 10, 2019 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, announced today that it has completed a definitive agreement for its previously announced joint venture with Rama First Nation to bring large-scale cannabis cultivation, extraction, and retail to Rama, Ontario and the surrounding region. The partnership’s first major project will be the construction of a large-scale cannabis production facility which will create at least 100 permanent jobs for Rama and area residents.  

DENVER, January 8, 2019 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today issued a letter to stakeholders from Rishi Gautam, Chairman and Chief Executive Officer, to provide an update on the Company’s business and growth strategy.  The letter can be found on the Company’s Investor Relations site and below.

DENVER – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced that its WILL cultivation facility in Brampton, Ontario has received its first license to sell cannabis under the Cannabis Act (Canada), which went into effect on October 17, 2018.

DENVER, Colorado – December 24, 2018 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced that the Company has been added to the CSE Composite Index, effective at the market close Friday, December 21, 2018.

Collaboration with Salamanca University and the Institute of Neuroscience of Castilla y León to Study the Benefits of Cannabinoids on Epilepsy and Schizophrenia.

DENVER, December 18, 2018 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced its first medical cannabis research investment to fund two studies on the benefits of cannabinoids on epilepsy and schizophrenia. 

DENVER, December 11, 2018 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, is pleased to announce that the recently opened cultivation and extraction facility in Lower Sackville, Nova Scotia owned by AtlantiCann Medical Inc. (“AMI”), in which MJardin has a 50% equity interest, has been granted a license by Health Canada for cannabis cultivation.

DENVER, December 4, 2018 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, is pleased to announce the closing on November 26, 2018 of a $6 million minority investment in OG DNA Genetics Inc. (“DNA Genetics”), a globally recognized leader in cannabis with operations in California, Canada and Europe. 

DENVER, December 3, 2018 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR), a  leader in cannabis management, today announced the closing of its acquisition of GrowForce Holdings Inc. (“GrowForce”), a vertically integrated international cannabis platform headquartered in Toronto and the release to the Company of the net proceeds of GrowForce’s July 2018 subscription receipt financing.

DENVER, Colorado - November 26, 2018 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced that it will release financial results for its third quarter ended September 30, 2018 before the stock market opens on Wednesday, November 28, 2018. The Company will hold a conference call for investors at 6:00 a.m. Mountain Time (8:00 a.m. Eastern Time) that same day.